MDXG Mimedx Group, Inc.

$3.67 +1.38%

Healthcare · Surgical & Medical Instruments & Apparatus

Mimedx Group, Inc. (MDXG) is a healthcare company in the Surgical & Medical Instruments & Apparatus industry, with a market capitalization of $547 million. Shares last traded at $3.67, 54.1% below their 52-week high. Over the past year the stock is down 36.7%. MDXG trades at a price-to-earnings ratio of 11.25, below the Surgical & Medical Instruments & Apparatus median of 28.73. Net profit margin is 11.6%, above the peer median of -7.6%. Revenue grew 20.0% year over year.

Market Cap

$547M

Shares Out

148.9M

EPS (TTM)

$0.31

P/E Ratio

11.84

P/S Ratio

1.31

P/B Ratio

2.25

Dividend / Share

—

Dividend Yield

—

52-Week High

$8.00

52-Week Low

$3.02

Volume

94,500

Avg Vol (3m)

95,678.063

Performance

-0.27%

+0.55%

-11.78%

-49.45%

YTD

-43.36%

-36.72%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

50.57

SMA (50)

$3.60

SMA (200)

$5.48

Price vs SMA50

+1.85%

Price vs SMA200

-33.07%

ATR (14)

$0.14

Financials

Revenue

$419M

Net Income

$49M

Gross Margin

82.6%

Operating Margin

15.3%

Net Margin

11.6%

Return on Equity

20.0%

Return on Assets

15.7%

Current Ratio

5.39

Debt / Equity

0.07

Revenue Growth (YoY)

+20.0%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$-0.07	2026-04-29
FY 2025	$0.32	2026-02-25
Q3 2025	$0.22	2025-10-29
Q2 2025	$0.11	2025-07-30
Q1 2026	$0.05	2026-04-29
FY 2025	$0.28	2026-02-25

Full earnings history →

Surgical & Medical Instruments & Apparatus peers

MDXG vs 14 industry peers (Surgical & Medical Instruments & Apparatus), by market cap.

P/E vs peers

11.25 / 28.73 med

-61% discount

P/S vs peers

1.31 / 2.52 med

-48% discount

Net margin vs peers

11.6% / -7.6% med

above median

1–14 of 14


SYK	Stryker Corporation	$118.1B	36.38	4.70	12.9%	+2.28%
MMM	3M	$83.9B	25.82	3.36	13.0%	+1.10%
BSX	Boston Scientific	$67.3B	23.27	3.35	14.4%	+0.64%
BDX	Becton Dickinson	$39.7B	23.64	1.82	7.7%	+1.62%
MDLN	Medline Inc.	$29.4B	—	—	—	-1.47%
DXCM	DexCom	$28.0B	33.43	6.00	17.9%	+1.69%
RMD	ResMed	$27.4B	19.53	5.32	27.2%	+1.24%
WST	West Pharmaceutical Services	$23.2B	46.92	7.54	16.1%	+1.35%
SOLV	Solventum	$13.1B	—	—	—	+1.21%
PEN	Penumbra Inc	$12.5B	70.18	8.88	12.7%	+0.28%
GMED	Globus Medical Inc	$10.8B	19.99	3.66	18.3%	+5.00%
BAX	Baxter International	$10.3B	-10.74	0.91	-8.5%	+2.58%
PODD	Insulet Corporation	$10.1B	40.84	3.73	9.1%	+1.51%
GKOS	Glaukos Corp	$7.7B	-40.92	15.13	-37.0%	+2.53%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.